1/ Blood cancer patients: We still don’t know how effective the current Covid 19 vaccinations will be in people with a blood cancer - it may be an ‘individual response’. A monoclonal antibody Covid 19 clinical trial, PROVENT, is looking at people with compromised immune systems..
2/ who may not respond to Covid 19 vaccinations. The experimental treatment is designed to encourage gradual release of antibodies ( passive vaccination, similar to IVIG), specific to Covid 19...
3/ This is an @AstraZeneca trial run by @uclh at multiple sites across England. If you would like to discuss further, I am back at my desk on Monday 4th Jan. Email me: [email protected] ...
4/ For further info, read this comprehensive info put together by @adrianwarnock https://bloodcanceruncensored.com/volunteering-for-a-monoclonal-antibody-covid19-clinical-trial/
5/ And, as always, talk to your treating team about your own personalised, individual risk. Blood cancers as we all know, are not a ‘one size fits all’. The absolute recommendation from haematologists globally is that if you have a blood cancer ...
6/ that you are protected, however is individually right for you, against Covid 19.
Thank you @BloodUncensored for this information!